RJFSA
RNAM

Raymond James Financial Services Advisors’s Avidity Biosciences RNAM Stock Holding History

Raymond James Financial Services Advisors’s Portfolio RNAM Stock Details RNAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$5.3M Buy
115,403
+3,370
+3% +$146K 0.01% 1191
2024
Q2 		$4.58M Sell
112,033
-7,551
-6% -$217K 0.01% 1218
2024
Q1 		$3.05M Buy
119,584
+32,973
+38% +$517K ﹤0.01% 1415
2023
Q4 		$784K Buy
86,611
+51,839
+149% +$347K ﹤0.01% 2124
2023
Q3 		$222K Buy
34,772
+8,700
+33% +$75K ﹤0.01% 2865
2023
Q2 		$289K Sell
26,072
-10,582
-29% -$133K ﹤0.01% 2682
2023
Q1 		$563K Buy
36,654
+20,951
+133% +$461K ﹤0.01% 2257
2022
Q4 		$348K Buy
+15,703
New +$234K ﹤0.01% 2488

Other funds holding RNAM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Raymond James Financial Services Advisors's RNAM Position: Q3 2024 in Review

Raymond James Financial Services Advisors increased its Avidity Biosciences (RNAM) stake by 3% in Q3 2024, buying an estimated $146K and bringing the position to 115,403 shares worth $5.3M. The position accounts for 0.01% of the portfolio, ranked #1191.

Raymond James Financial Services Advisors first reported a position in RNAM in Q4 2022 and has held it in 8 quarters since. 245 funds tracked by Wall St. Rank hold RNAM as of Q3 2024.

  • Raymond James Financial Services Advisors held 115,403 shares of Avidity Biosciences worth $5.3M as of Q3 2024.
  • Raymond James Financial Services Advisors bought 3,370 Avidity Biosciences shares in Q3 2024, an estimated $146K.
  • Avidity Biosciences made up 0.01% of Raymond James Financial Services Advisors's portfolio in Q3 2024, its #1191 holding.
  • Raymond James Financial Services Advisors first reported a position in Avidity Biosciences in Q4 2022 and has held it in 8 quarters since.
  • 245 funds tracked by Wall St. Rank held Avidity Biosciences as of Q3 2024.

Based on Raymond James Financial Services Advisors's 13F filing for Q3 2024, filed 18 Oct 2024.